IntelGenx appoints Rajiv Khosla senior consultant
This article was originally published in Scrip
Dr Rajiv Khosla has joined IntelGenx's management team in a senior consulting capacity, effective 1 January 2013. Initially, Dr Khosla will assist IntelGenx with strategic operations and business development activities, but it is anticipated that in April 2013 he will be appointed chief operating officer and chief scientific officer, both of which will be newly created positions. Dr Khosla has been serving as a member of IntelGenx's board but will resign his seat as he begins his new role. Most recently, he served as president and CEO of Orasi Medical.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.